Results 51 to 60 of about 2,000,070 (348)
Pediatric Blood &Cancer, EarlyView.ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson +3 more
wiley +1 more source
Turkish Journal of Hematology, 2014 OBJECTIVE: Hemophilia B is caused by coagulation defects in the factor IX gene located in Xq27.1 on the X chromosome. A wide range of mutations, showing extensive molecular heterogeneity, have been described in hemophilia B patients.
Dong Hua Cao +7 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Objective To evaluate the diagnostic yield and utility of universal paired tumor–normal multigene panel sequencing in newly diagnosed pediatric solid and central nervous system (CNS) tumor patients and to compare the detection of germline pathogenic/likely pathogenic variants (PV/LPVs) against established clinical referral criteria for cancer ...
Natalie Waligorski +9 more
wiley +1 more source
The Clinical Genetics of Hemophilia B (Factor IX Deficiency)
The Application of Clinical Genetics, 2021 Connie H Miller1,2 1Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA; 2Synergy America, Inc., Duluth, GA, USACorrespondence: Connie H MillerDivision
Miller CH
doaj
Efficacy of a high-purity factor IX concentrate in hemophilia B patients undergoing surgery [PDF]
Revista Brasileira de Hematologia e Hemoterapia, 2002 A plasma derived, high purity, solvent-detergent treated and subsequently nanofiltered factor IX concentrate (BEMOFIL) was evaluated in 19 hemophilia B patients, including four with severe, thirteen with mild or moderate type of disease and two ...
Vesa Rasi, Freja Ebeling
doaj +1 more source
Pion Form Factor in the Light-Front
, 2004 The pion electromagnetic form factor is calculated with a light-front quark model. The "plus" and "minus" component of the electromagnetic current are used to calculate the electromagnetic form factor in the Breit frame with two models for the q\bar{q ...
de Melo, J. P. B. C.
core +1 more source
Implication of the proton-deuteron radiative capture for Big Bang Nucleosynthesis [PDF]
, 2015 The astrophysical $S$-factor for the radiative capture $d(p,\gamma)^3$He in the energy-range of interest for Big Bang Nucleosynthesis (BBN) is calculated using an {\it ab-initio} approach.
Kievsky, A. +3 more
core +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Purpose Although not always achieved, complete chemotherapy‐induced nausea and vomiting (CINV) control is the conventional goal of CINV prophylaxis. In this two‐center, mixed‐methods study, we sought to understand the preferences of adolescent patients and family caregivers for CINV control endpoints.
Haley Newman +8 more
wiley +1 more source
Cochlear implantation in hemophilia B—a rare case report
The Egyptian Journal of Otolaryngology, 2022 Background Hemophilia B is an X-linked inherited disease, mainly caused by deficiency of factor IX. Severity of the disease is manifested by the factor IX deficiency in the blood.
Chetan Yadav +3 more
doaj +1 more source
Microscopic calculation of the inclusive electron scattering structure function in O-16
, 1999 We calculate the charge form factor and the longitudinal structure function for $^{16}$O and compare with the available experimental data, up to a momentum transfer of 4 fm$^{-1}$.
A. Kievsky +26 more
core +1 more source